Death Receptor 5 Internalization is Required for Lysosomal Permeabilization by TRAIL in Malignant Liver Cell Lines

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2009 Mar 11

PMID 19272388

Citations 41

Authors

Yuko Akazawa

Justin L Mott

Steven F Bronk

Nathan W Werneburg

Alisan Kahraman

Maria Eugenia Guicciardi

Xue Wei Meng

Shigeru Kohno

Vijay H Shah

Scott H Kaufmann

Mark A McNiven

Gregory J Gores

Affiliations

Soon will be listed here.

Abstract

Background & Aims: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity in hepatocellular carcinoma cells is mediated by lysosomal permeabilization. Our aims were to determine which TRAIL receptor, death receptor (DR) 4 or DR5, mediates lysosomal permeabilization and assess whether receptor endocytosis followed by trafficking to lysosomes contributes in this process.

Methods: TRAIL ligand internalization in Huh-7 cells was examined by confocal microscopy using Flag-tagged TRAIL, whereas DR4- and DR5-enhanced green fluorescent protein internalization was assessed by total internal reflection microscopy. Clathrin-dependent endocytosis was inhibited by expressing dominant negative dynamin.

Results: Although Huh-7 cells express both TRAIL receptors, short hairpin RNA silencing of DR5 but not DR4 attenuated TRAIL-mediated lysosomal permeabilization and apoptosis. The TRAIL/DR5 complex underwent rapid cellular internalization upon ligand stimulation, whereas the TRAIL/DR4 complex was not efficiently internalized. DR5-enhanced green fluorescent protein internalization was dependent on a dileucine-based internalization motif. Endocytosis of the TRAIL/DR5 complex was dynamin dependent and was required for rapid lysosomal permeabilization and apoptosis in multiple malignant hepatocellular and cholangiocarcinoma cell lines. Upon TRAIL treatment, DR5 colocalized with lysosomes after internalization. Inhibition of DR5 trafficking to lysosomes by Rab7 small interfering RNA also reduced TRAIL-mediated lysosomal disruption and apoptosis.

Conclusions: TRAIL-mediated endocytosis of DR5 with trafficking to lysosomes contributes to lysosomal protease release into the cytosol and efficient apoptosis in malignant liver cell lines.

Citing Articles

Endoplasmic reticulum stress regulates apoptosis and chemotherapeutic via enhancing TNFRSF10B recycling to the cell membrane in triple-negative breast cancer.

Zhao D, Song J, Ji C Clin Transl Oncol. 2024; 27(1):265-276.

PMID: 38967737 DOI: 10.1007/s12094-024-03509-1.

Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.

Luo Y, Hao H, Wang Z, Ong C, Dutcher R, Xu Y bioRxiv. 2023; .

PMID: 37546770 PMC: 10402122. DOI: 10.1101/2023.07.26.550758.

Lewis glycosphingolipids as critical determinants of TRAIL sensitivity in cancer cells.

Fukuoka T, Moriwaki K, Takamatsu S, Kondo J, Tanaka-Okamoto M, Tomioka A Oncogene. 2022; 41(38):4385-4396.

PMID: 35970887 DOI: 10.1038/s41388-022-02434-3.

The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe?.

Zou M, Zeng Q, Nie J, Yang J, Luo Z, Gan H Front Immunol. 2021; 12:769167.

PMID: 34956195 PMC: 8692584. DOI: 10.3389/fimmu.2021.769167.

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL.

Artykov A, Yagolovich A, Dolgikh D, Kirpichnikov M, Trushina D, Gasparian M Front Cell Dev Biol. 2021; 9:733688.

PMID: 34660590 PMC: 8514705. DOI: 10.3389/fcell.2021.733688.

References

Roberts L, Kurosawa H, Bronk S, Fesmier P, Agellon L, Leung W . Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology. 1997; 113(5):1714-26. DOI: 10.1053/gast.1997.v113.pm9352877. View

Letourneur F, Klausner R . A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell. 1992; 69(7):1143-57. DOI: 10.1016/0092-8674(92)90636-q. View

Yagita H, Takeda K, Hayakawa Y, Smyth M, Okumura K . TRAIL and its receptors as targets for cancer therapy. Cancer Sci. 2004; 95(10):777-83. PMC: 11159975. DOI: 10.1111/j.1349-7006.2004.tb02181.x. View

Werneburg N, Guicciardi M, Bronk S, Kaufmann S, Gores G . Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J Biol Chem. 2007; 282(39):28960-28970. DOI: 10.1074/jbc.M705671200. View

Nagamatsu S . TIRF microscopy analysis of the mechanism of insulin exocytosis. Endocr J. 2006; 53(4):433-40. DOI: 10.1507/endocrj.kr-75. View

Vitelli R, Santillo M, Lattero D, Chiariello M, Bifulco M, Bruni C . Role of the small GTPase Rab7 in the late endocytic pathway. J Biol Chem. 1997; 272(7):4391-7. DOI: 10.1074/jbc.272.7.4391. View

Shaw R, Fay A, Puthenveedu M, Von Zastrow M, Jan Y, Jan L . Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell. 2007; 128(3):547-60. PMC: 1955433. DOI: 10.1016/j.cell.2006.12.037. View

Kimberley F, Screaton G . Following a TRAIL: update on a ligand and its five receptors. Cell Res. 2004; 14(5):359-72. DOI: 10.1038/sj.cr.7290236. View

Scaffidi C, Schmitz I, Zha J, Korsmeyer S, Krammer P, Peter M . Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem. 1999; 274(32):22532-8. DOI: 10.1074/jbc.274.32.22532. View

10.

Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J . Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity. 2004; 21(3):415-28. DOI: 10.1016/j.immuni.2004.08.017. View

11.

Ceresa B, Bahr S . rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome. J Biol Chem. 2005; 281(2):1099-106. DOI: 10.1074/jbc.M504175200. View

12.

van der Sloot A, Tur V, Szegezdi E, Mullally M, Cool R, Samali A . Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor. Proc Natl Acad Sci U S A. 2006; 103(23):8634-9. PMC: 1482632. DOI: 10.1073/pnas.0510187103. View

13.

Guicciardi M, Bronk S, Werneburg N, Gores G . cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis. Am J Physiol Gastrointest Liver Physiol. 2007; 292(5):G1337-46. DOI: 10.1152/ajpgi.00497.2006. View

14.

Kohlhaas S, Craxton A, Sun X, Pinkoski M, Cohen G . Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J Biol Chem. 2007; 282(17):12831-41. DOI: 10.1074/jbc.M700438200. View

15.

Dale L, Seachrist J, Babwah A, Ferguson S . Regulation of angiotensin II type 1A receptor intracellular retention, degradation, and recycling by Rab5, Rab7, and Rab11 GTPases. J Biol Chem. 2004; 279(13):13110-8. DOI: 10.1074/jbc.M313333200. View

16.

Huang F, Kirkpatrick D, Jiang X, Gygi S, Sorkin A . Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Mol Cell. 2006; 21(6):737-48. DOI: 10.1016/j.molcel.2006.02.018. View

17.

Ashkenazi A, Herbst R . To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest. 2008; 118(6):1979-90. PMC: 2396896. DOI: 10.1172/JCI34359. View

18.

Austin C, Lawrence D, Peden A, Varfolomeev E, Totpal K, De Maziere A . Death-receptor activation halts clathrin-dependent endocytosis. Proc Natl Acad Sci U S A. 2006; 103(27):10283-10288. PMC: 1482799. DOI: 10.1073/pnas.0604044103. View

19.

Kurosawa H, Que F, Roberts L, Fesmier P, Gores G . Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol. 1997; 272(6 Pt 1):G1587-93. DOI: 10.1152/ajpgi.1997.272.6.G1587. View

20.

Finnberg N, Klein-Szanto A, El-Deiry W . TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis. J Clin Invest. 2007; 118(1):111-23. PMC: 2129232. DOI: 10.1172/JCI29900. View